0 Yorumlar
0 hisse senetleri
621 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Manufacturing Innovation: How Cell Therapy Manufacturing Is Advancing Regenerative MedicineThe Cell Therapy Technologies Market is experiencing explosive growth as cell therapy manufacturing continues to advance regenerative medicine and personalized treatment approaches. According to market reports, the global Cell Therapy Technologies Market was valued at USD 6.54 billion in 2024 and is projected to reach USD 17.46 billion by 2030, rising at a CAGR of 17.84% . This...0 Yorumlar 0 hisse senetleri 737 Views 0 önizleme
-
Pharmaceutical Investment Chamber of Commerce and IndustryPharmaceutical Investment Chamber of Commerce and Industry & Supporting Growth in the Pharma Sector The pharmaceutical sector plays an essential role in public health, economic development, and scientific progress. It connects medicine manufacturing, research, distribution, packaging, quality assurance, and healthcare innovation. As demand for reliable medical products continues to...0 Yorumlar 0 hisse senetleri 8 Views 0 önizleme
-
Pharmaceutical Manufacturing Market Growth: Key Opportunities for Industry PlayersPharmaceutical Manufacturing Market to Reach USD 1,318.3 Billion by 2033 Overview According to the supplied market estimates, the global Pharmaceutical Manufacturing Market is projected to grow from USD 557.6 billion in 2025 to USD 1,318.3 billion by 2033, registering a compound annual growth rate (CAGR) of 11.8%. This growth reflects increasing pharmaceutical demand, technological...0 Yorumlar 0 hisse senetleri 50 Views 0 önizleme
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme